Compare NBTX & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTX | DEC |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2020 | N/A |
| Metric | NBTX | DEC |
|---|---|---|
| Price | $24.85 | $13.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $26.00 | $21.40 |
| AVG Volume (30 Days) | 22.3K | ★ 538.4K |
| Earning Date | 04-01-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 8.78% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $11,930,711.00 | ★ $1,148,432,000.00 |
| Revenue This Year | N/A | $126.94 |
| Revenue Next Year | $145.24 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 64.19 |
| 52 Week Low | $2.95 | $10.08 |
| 52 Week High | $30.35 | $17.03 |
| Indicator | NBTX | DEC |
|---|---|---|
| Relative Strength Index (RSI) | 60.40 | 49.68 |
| Support Level | $22.76 | $12.80 |
| Resistance Level | $25.55 | $13.59 |
| Average True Range (ATR) | 1.13 | 0.41 |
| MACD | 0.40 | 0.07 |
| Stochastic Oscillator | 72.91 | 71.36 |
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Diversified Energy Co is an independent energy company focused on natural gas and liquids production, transportation, marketing and well retirement, located within the Appalachian and Central regions of the United States. Its principal focus is on enhancing producing wells, not drilling new wells, thereby allowing it to optimise PDP revenues and reduce costs. The company derives revenues from the sale of oil, natural gas and natural gas liquids.